Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis

NCT04753034 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: TER-101
DRUG: Vehicle

Sponsor

Teres Bio, Inc.